Drugs / PVS-10200
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01099215 | Apr 2010 → Jun 2012 | peripheral arterial disease | Shire | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PVS-10200 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01099215 ↗ |
| Modality | Cell therapy | “an allogeneic cellular therapy” NCT01099215 ↗ |
| Route | Other | “delivered by ultrasound guided injection to the perivascular region” NCT01099215 ↗ |